Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Most popular news headlines for Tuesday, August 5 2014
CP Wire
Tue, 08/5/14 - 11:40 pm
Tags:
Actavis, ebola virus, GSK, M&A, Mapp Biopharmaceutical, Novo Nordisk, Pfizer
Tue, 08/5/14 - 11:38 pm
Tags:
GSK, Novo Nordisk, Actavis, Pfizer, M&A, ebola virus, Mapp Biopharmaceutical
Novo Nordisk Leapfrogs Glaxo as U.K. Drug Giant Declines
Bloomberg
Tue, 08/5/14 - 08:01 am
Tags:
Novo Nordisk, GSK, insulin, diabetes
Novo sees two-in-one diabetes drug in Europe in H1 2015
Reuters
Fri, 07/25/14 - 09:14 am
Tags:
Novo Nordisk, diabetes, Europe, insulin
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise
Seeking Alpha
Mon, 07/21/14 - 10:19 am
Tags:
MannKind, Afrezza, diabetes, AstraZeneca, GSK, Eli Lilly, Novo Nordisk, Merck
3 Stocks Advancing The Drugs Industry
TheStreet.com
Wed, 07/16/14 - 05:29 pm
Tags:
Novo Nordisk, Pfizer, Valeant Pharmaceuticals
Novo Nordisk Gets FDA Nod for NovoSeven RT
Yahoo/Zacks.com
Tue, 07/8/14 - 04:55 pm
Tags:
Novo Nordisk, FDA, NovoSeven
Novo Nordisk's Diabetes Pill Shows Promise
Seeking Alpha
Fri, 06/27/14 - 09:37 am
Tags:
diabetes, Novo Nordisk, Merrion, Emisphere, semaglutide, NN9924
Novo Nordisk exec: We'll double sales within 10 years
Fierce Pharma
Wed, 06/25/14 - 05:29 pm
Tags:
Novo Nordisk
Who Will Win This $45 Billion Market?
Motley Fool
Sat, 06/21/14 - 11:45 am
Tags:
Sanofi, Novo Nordisk, diabetes, type 1 diabetes, type 2 diabetes
Will These 3 Products Revolutionize Diabetes Treatment?
Motley Fool
Sun, 06/15/14 - 06:58 pm
Tags:
diabetes, MannKind, Afrezza, Novo Nordisk, Apple
Novo Nordisk diabetes drug appears effective for weight loss -study
Yahoo/Reuters
Sun, 06/15/14 - 10:44 am
Tags:
Novo Nordisk, obesity, diabetes, Victoza
Diabetes: The $54 billion battleground
CNBC
Fri, 06/13/14 - 12:26 pm
Tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca
Novo Nordisk profit up 8%; warns on sales growth
Marketwatch
Thu, 05/1/14 - 08:29 am
Tags:
earnings, Novo Nordisk
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Seeking Alpha
Wed, 04/16/14 - 09:37 am
Tags:
Lyxumia, GLP-1 agonist, Sanofi, Novo Nordisk, diabetes, Victoza
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
Tags:
diabetes, Takeda, Sanofi, GSK, Victoza, Merck, insulin, Novo Nordisk, Afrezza, U300, Tresiba, Eli Lilly
Novo CEO sees improved picture for Tresiba in U.S. market
Fierce Pharma
Mon, 03/24/14 - 12:13 pm
Tags:
Novo Nordisk, Pharma CEOs, Tresiba, diabetes, Sanofi, insulin
Novo Nordisk sees chance of U.S. Tresiba launch before rival products
Yahoo/Reuters
Thu, 03/20/14 - 05:35 pm
Tags:
Novo Nordisk, insulin, diabetes, Tresiba, Lantus, Sanofi, Eli Lilly
Novo reports positive results from phase 3 trial with NovoEight
Reuters
Wed, 03/19/14 - 04:11 pm
Tags:
Novo Nordisk, NovoEight, hemophilia A
Novo Nordisk taps bankers for potential IT unit spinoff
Fierce Pharma
Tue, 03/18/14 - 12:16 pm
Tags:
Novo Nordisk, spinoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.